إعلان
إعلان

PGEN

PGEN logo

Precigen, Inc. Common Stock

4.59
USD
برعاية
-0.02
-0.52%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

4.59

+0.01
+0.20%

تقارير أرباح PGEN

النسبة الإيجابية المفاجئة

PGEN تفوق 11 من 40 آخر التقديرات.

28%

التقرير التالي

بيانات التقرير القادم
١٧ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$8.45M
/
-$0.08
التغير الضمني من Q3 25 (Revenue/ EPS)
+189.23%
/
-92.45%
التغير الضمني من Q4 24 (Revenue/ EPS)
+610.20%
/
+33.33%

Precigen, Inc. Common Stock earnings per share and revenue

On ١٣ نوفمبر ٢٠٢٥, PGEN reported earnings of -1.06 USD per share (EPS) for Q3 25, missing the estimate of -0.09 USD, resulting in a -993.91% surprise. Revenue reached 2.92 مليون, compared to an expected 510.00 ألف, with a 472.94% difference. The market reacted with a +25.65% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of -0.08 USD, with revenue projected to reach 8.45 مليون USD, implying an نقصان of -92.45% EPS, and زيادة of 189.23% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Precigen, Inc. Common Stock reported EPS of -$1.06, missing estimates by -993.91%, and revenue of $2.92M, 472.94% above expectations.
The stock price moved up 25.65%, changed from $3.86 before the earnings release to $4.85 the day after.
The next earning report is scheduled for ١٧ مارس ٢٠٢٦.
Based on 5 المحللين, Precigen, Inc. Common Stock is expected to report EPS of -$0.08 and revenue of $8.45M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان